Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.

about

Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.

Item

http://www.wikidata.org/entity/Q44509146

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Safety and feasibility of intr ...... unit: an observational study.

@en

Safety and feasibility of intr ...... unit: an observational study.

@nl

type

Item

label

Safety and feasibility of intr ...... unit: an observational study.

@en

Safety and feasibility of intr ...... unit: an observational study.

@nl

prefLabel

Safety and feasibility of intr ...... unit: an observational study.

@en

Safety and feasibility of intr ...... unit: an observational study.

@nl

P1476

Safety and feasibility of intr ...... unit: an observational study.

@en

P2093

Andrea Tampieri

http://www.w3.org/2001/XMLSchema#string

Anna Maria Rusconi

http://www.w3.org/2001/XMLSchema#string

Daniela Bendanti

http://www.w3.org/2001/XMLSchema#string

Eugenio Giovannini

http://www.w3.org/2001/XMLSchema#string

Lorenzo Cristoni

http://www.w3.org/2001/XMLSchema#string

Patrizia Cenni

http://www.w3.org/2001/XMLSchema#string

Tiziano Lenzi

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

Classification and natural history of clinically identifiable subtypes of cerebral infarction

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Tissue plasminogen activator for acute ischemic stroke

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

Stroke incidence and prevalence in Europe: a review of available data.

A comprehensive review of prehospital and in-hospital delay times in acute stroke care.

P2888

s11739-014-1153-9

P304

181-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11739-014-1153-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25430677

http://www.w3.org/2001/XMLSchema#string